Literature DB >> 12678678

Hydroxyquinolines as iron chelators.

J-L Pierre1, P Baret, G Serratrice.   

Abstract

The interest in synthetic siderophore mimics includes therapeutic applications (iron chelation therapy), the design of more effective agents to deliver Fe to plants and the development of new chemical tools for studies of iron metabolism and for a better understanding of iron assimilation processes in living systems. The 8-hydroxyquinoline bidentate chelate moiety offers an alternative to the usual hydroxamic acid, catechol and/or alpha-hydroxycarboxylic acid metal-binding groups encountered in natural siderophores. The promising results obtained by the tris hydroxyquinoline-based ligand O-TRENSOX are summarized. O-TRENSOX exhibits a high and selective affinity for Fe(III) complexation. Its efficiency in delivering Fe to plants as well as its efficiency for iron mobilization, cellular protection and antiproliferative effects have been evidenced. Other chelators of the O-TRENSOX family (mixed catechol / 8-hydroxyquinoline ligands, lipophilic ligands) are also described. Some results question whether the use of partition coefficients is pertinent to foresee the activity of iron chelators. The development of probes (fluorescent, radioactive, spin labelled) based on the O-TRENSOX backbone is in progress. 8-hydroxyquinoline iron chelators seem to have a promising future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12678678     DOI: 10.2174/0929867033457584

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  13 in total

1.  Identification of compounds selectively killing multidrug-resistant cancer cells.

Authors:  Dóra Türk; Matthew D Hall; Benjamin F Chu; Joseph A Ludwig; Henry M Fales; Michael M Gottesman; Gergely Szakács
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

3.  Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease.

Authors:  Balaram Ghosh; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

4.  Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity.

Authors:  Guang Huang; Claribel Murillo Solano; Yuxin Su; Nameer Ezzat; Shino Matsui; Liuyu Huang; Debopam Chakrabarti; Yu Yuan
Journal:  Tetrahedron Lett       Date:  2019-05-28       Impact factor: 2.415

5.  (E)-N'-(3,4-Dimethoxy-benzyl-idene)-2-(8-quinol-yloxy)acetohydrazide-methanol-water (1/1/1).

Authors:  Zhan-Ling Ma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-11-28

6.  N,N-Dicyclo-hexyl-2-(5,7-dichloro-8-quinol-yloxy)acetamide.

Authors:  Jing-Lin Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-07

7.  A Fluorescent Sensor for Al(III) and Colorimetric Sensor for Fe(III) and Fe(II) Based on a Novel 8-Hydroxyquinoline Derivative.

Authors:  Negar Lashgari; Alireza Badiei; Ghodsi Mohammadi Ziarani
Journal:  J Fluoresc       Date:  2016-07-21       Impact factor: 2.217

Review 8.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

9.  Chelators in the treatment of iron accumulation in Parkinson's disease.

Authors:  Ross B Mounsey; Peter Teismann
Journal:  Int J Cell Biol       Date:  2012-06-13

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.